dr.

(Isaac) I Corro Ramos MSc

Profile

Isaac Corro Ramos was born in Sevilla, Spain, on March 24th, 1977. He obtained his Master’s degree in Mathematics (option Statistics and Operations Research) from the University of Sevilla in June 2001. Between June 2001 and July 2005 Isaac had several jobs in different working areas and countries. He worked as a high-school Mathematics teacher in Sevilla (Spain), as a software programmer in Madrid (Spain) and Vienna (Austria), and as a researcher in Rome (Italy). In July 2005 he started his Ph.D. at the Department of Mathematics and Computer Science of the Eindhoven University of Technology working on the STRESS (Statistical Testing and Reliability Estimation of Software Systems) project. He defended his thesis on December 15, 2009.

Since August 2009 Isaac works as a scientific researcher at the Institute for Medical Technology Assessment (iMTA) in Rotterdam, The Netherlands. Since he enrolled iMTA he has worked in several research projects whose subjects include probabilistic modelling, cost-effectiveness analysis of health care technologies, value of information analysis and discrete event simulation.

• All publications (24)

  • Article (22)

    • Scholarly Publication (21)

      • V.J. Wester, S. de Groot, T.A. Kanters, L. Wagner, J. Ardesch, I. Corro Ramos, M.J. Enders-Slegers, M. de Ruiter, S. le Cessie, J. Los, G. Papageorgiou, N.J.A. van Exel & M.M. Versteegh (2020). Evaluating the Effectiveness and Cost-Effectiveness of Seizure Dogs in Persons With Medically Refractory Epilepsy in the Netherlands: Study Protocol for a Stepped Wedge Randomized Controlled Trial (EPISODE). FRONTIERS IN NEUROLOGY, 11 (3). doi: 10.3389/fneur.2020.00003 [go to publisher's site]
      • I. Corro Ramos, E.J.I. Hoogendoorn - Lips & M.P.M.H. Rutten - van Molken (2020). How to Address Uncertainty in Health Economic Discrete-Event Simulation Models: An Illustration for Chronic Obstructive Pulmonary Disease. Medical Decision Making, 40, 619-632. doi: 10.1177/0272989X20932145.
      • M. Hoogendoorn, I. Corro Ramos, M. Baldwin, N. Gonzalez-Rojas Guiz & M.P.M.H. Rutten - van Molken (2019). Broadening the perspective of cost-effectiveness modeling in COPD: a new patient-level simulation model suitable to evaluate stratified medicine. Value in Health, 22, 313-332. doi: 10.1016/j.jval.2018.10.008 [go to publisher's site]
      • M. Hoogendoorn, I. Corro Ramos, M. Baldwin, L. Luciani, C. Fabron, B. Detournay & M.P.M.H. Rutten - van Molken (2019). Long-term cost-effectiveness of the fixed-dose combination tiotropium plus olodaterol based on the DYNAGITO trial results. Int J COPD. The International Journal of Chronic Obstructive Pulmonary Disease, 14, 447-456. doi: 10.2147/COPD.S191031 [go to publisher's site]
      • S.A. Huygens, M.P.M.H. Rutten - van Molken, A. Noruzi, J.R.G. Etnel, I. Corro Ramos, C. Bouten, J. Kluin & J.J.M. Takkenberg (2019). What Is the Potential of Tissue-Engineered Pulmonary Valves in Children? Annals of Thoracic Surgery, 107 (6), 1845-1853. doi: 10.1016/j.athoracsur.2018.11.066
      • M.M. Versteegh, I. Corro Ramos, N.C. Buyukkaramikli, A. Ansaripour, V.T. Reckers - Droog & W.B.F. Brouwer (2019). Severity-Adjusted Probability of Being Cost Effective. Pharmacoeconomics (Print), 37, 1155-1163. doi: 10.1007/s40273-019-00810-8 [go to publisher's site]
      • M.G. Franken, I. Corro Ramos, J. Los & M.J. Al (2018). The increasing importance of a continence nurse specialist to improve outcomes and save costs of urinary incontinence care: an analysis of future policy scenarios. BMC Family Practice, 19 (31). doi: 10.1186/s12875-018-0714-9 [go to publisher's site]
      • W.F. Thielen, N.C. Büyükkaramikli, R. Riemsma, D. Fayter, N. Armstrong, C. Wei, V. Huertas Carrera, K. Misso, G. Worthy, J. Kleijnen & I. Corro Ramos (2018). Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma. Pharmacoeconomics (Print). doi: 10.1007/s40273-018-0740-4 [go to publisher's site]
      • I. Corro Ramos, M.M. Versteegh, J.M. Koenders, G.C. Linssen, J. Meeder & M.P.M.H. Rutten - van Molken (2017). Cost-Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands: A Country Adaptation Analysis Under the Former and Current Dutch Pharmacoeconomic Guidelines. Value in Health. doi: 10.1016/j.jval.2017.05.013
      • I. Corro Ramos, G.A.K. van Voorn, P. Vemer, T. Feenstra & M.J. Al (2017). A New Statistical Method to Determine the Degree of Validity of Health Economic Model Outcomes against Empirical Data. Value in Health, 20 (8), 1041-1047. doi: 10.1016/j.jval.2017.04.016
      • M. Westwood, S. Lang, N. Armstrong, S. van Turenhout, J. Cubiella, L. Stirk, I. Corro Ramos, M. Luyendijk, R. Zaim, J. Kleijnen & C.G. Fraser (2017). Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance. BMC Medicine, 15:189. doi: 10.1186/s12916-017-0944-z
      • I. Corro Ramos, S. Lhachimi, A. Gerber-Grote & M.J. Al (2016). Cost Recommendation under Uncertainty in IQWiG’s Efficiency Frontier Framework. Medical Decision Making. doi: 10.1177/0272989X16636856
      • J. Bindels, B. Ramaekers, I. Corro Ramos, L. Mohseninejad, S. Knies, J. Grutters, M. Postma, M.J. Al, T. Feenstra & M. Joore (2016). Use of Value of Information in Healthcare Decision Making: Exploring Multiple Perspectives. Pharmacoeconomics (Print), 34 (3), 315-322. doi: 10.1007/s40273-015-0346-z
      • P. Vemer, I. Corro Ramos, G.A.K. van Voorn, M.J. Al & T. Feenstra (2016). AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users. Pharmacoeconomics (Print), 34 (4), 349-361. doi: 10.1007/s40273-015-0327-2
      • R. Riemsma, I. Corro Ramos, R. Birnie, N.C. Buyukkaramikli, N. Armstrong, S. Ryder, S. Duffy, G. Worthy, M.J. Al, J.L. Severens & J. Kleijnen (2016). Integrated sensor-augmented pump therapy system [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation. Health Technology Assessment, 20 (17). doi: 10.3310/hta20170
      • G.A.K. van Voorn, P. Vemer, D. Hamerlijnck, I. Corro Ramos, G.J. Teunissen, M. Al & T.L. Feenstra (2016). The Missing Stakeholder Group: Why Patients Should be Involved in Health Economic Modelling. Applied Health Economics and Health Policy, 14 (2), 129-133. doi: 10.1007/s40258-015-0200-7
      • V. Ignatyeva, J.L. Severens, I. Corro Ramos, G.R. Galstyan & M.V. Avxentyeva (2015). Costs of Hospital Stay in Specialized Diabetic Foot Department in Russia. Value in Health Regional Issues, 7C, 80-86. doi: 10.1016/j.vhri.2015.09.003
      • O. Mandrik, I. Corro Ramos, S. Knies, M.J. Al & J.L. Severens (2015). Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for treatment of chronic lymphocytic leukemia in Ukraine. Cancer Management and Research (online), 2015 (7), 279-289. doi: 10.2147/CMAR.S79258
      • I. Corro Ramos, M.P.M.H. Rutten - van Molken & M.J. Al (2015). Determining the Impact of Modeling Additional Sources of Uncertainty in Value-of-Information Analysis. Value in Health, 18 (1), 100-109. doi: 10.1016/j.jval.2014.09.003.
      • I. Corro Ramos, M.P.M.H. Rutten - van Molken & M.J. Al (2013). The role of value-of-information analysis in a health care research priority setting: a theoretical case study. Medical Decision Making, 33 (4), 472-489. doi: 10.1177/0272989X12468616
      • P. Vemer, P.F.M. Krabbe, T.L. Feenstra, G.A.K. van Voorn, I. Corro Ramos & M.J. Al (2013). Improving model validation in health technology assessment: comments on guidelines of the ISPOR-SMDM modeling good research practices task force. Value in Health, 16, 1106-1107. doi: 10.1016/j.jval.2013.06.015

    • Professional Publication (1)

      • O. Mandrik, I. Corro Ramos, O. Zalis'ka, A. Gaisenko & J.L. Severens (2013). Cost for Treatment of Chronic Lymphocytic Leukemia in Specialized Institutions of Ukraine. Value in Health, 2, 205-209. doi: 10.1016/j.vhri.2013.06.006

  • Report (2)

    • P. Whiting, M.J. Al, M. Westwood, I. Corro Ramos, S. Ryder, N. Armstrong, K. Misso, J. Ross, J.L. Severens & J. Kleijnen (2016). Viscoelastic point-of-care testing to assist with the diagnosis management and monitoring of haemostasis a systematic review and cost-effectiveness analysis. (Extern rapport, 19, no 58). : Health Technology Assessment doi: 10.3310/hta19580
    • R. Riemsma, M.J. Al, I. Corro Ramos, S.N. Deshpande, N. Armstrong, Y.C. Lee, S. Ryder, C. Noake, H.M. Krol, M. Oppe, J. Kleijnen & J.L. Severens (2013). SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis. (Extern rapport). Southampton: National Institute for Health Research doi: 10.3310/hta17610

• Teaching (3)

  Master Thesis HEPL

  Title

  Master Thesis HEPL

  Year

  2020

  Year level

  master

  Advanced Health Economic Modelling

  Title

  Advanced Health Economic Modelling

  Year

  2020

  Year level

  master, master, master

  Advanced Health Economic Modelling EuHEM

  Title

  Advanced Health Economic Modelling EuHEM

  Year

  2020

  Year level

  master

• Present position

  (external) researcher

  University

  Erasmus University Rotterdam

  School

  Erasmus School of Health Policy & Management

  Department

  Health Technology Assessment (HTA)

  Country

  The Netherlands

  Telephone

  0104081829